Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: AB Science, Aim Immunotech, Astellas, Astrazeneca, Basilea, Biontech, Eisai, Everest Medicines, Glenmark, Humanigen, I-Mab, Immunoforge, JW, Kintor, Lipidor, Liscure, Moderna, Pfizer, Takeda, Transcenta, Vifor Fresenius Medical Care Renal Pharma.